Credibility and governance signals rise alongside cure trial growth

Active cure trials now total 21,303 worldwide—evidence that the cure pipeline remains busy even as the capital/AI phase transition accelerates. In the last 24 hours, the Wire detected 24 new paradigm/platform governance signals and 16 new cure research items, but one theme stands out: legitimacy is becoming a gating constraint. OpenAI’s claim that an agent solved Navier–Stokes drew immediate scrutiny from mathematicians who question utility and independence, underscoring that human verification still determines what counts as mathematics. Meanwhile, proposals to centralize AI control (“AI force” and an “AI czar”) and cross-border cooperation aimed at managing rapid capability growth point to a governance catch-up cycle—one that, if handled responsibly, can widen the window for safely deploying AI into cure work. The window is still open.